Goldman Sachs
GRNAW

Goldman Sachs’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Goldman Sachs’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,883
Closed -$23K – 6636
2021
Q1 		$23K Buy
+26,883
New +$28K ﹤0.01% 6005

Other funds holding GRNAW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Goldman Sachs's GRNAW Position: Q2 2021 in Review

Goldman Sachs sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q2 2021, closing a stake of 26,883 shares — an estimated $23K sold.

Goldman Sachs first reported a position in GRNAW in Q1 2021 and held it in 1 quarter. The position peaked at $23K in Q1 2021. 22 funds tracked by Wall St. Rank hold GRNAW as of Q2 2021.

  • Goldman Sachs reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 26,883 GreenLight Biosciences Holdings, PBC Warrant shares in Q2 2021, an estimated $23K.
  • Goldman Sachs first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 1 quarter.
  • Goldman Sachs's GreenLight Biosciences Holdings, PBC Warrant position peaked at $23K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.